KOSPI · 009420
HANALL BIOPHARMA
Market cap₩2.26T
PERN/A
PBR13.62×
Foreign ownership4.84%
Avg. analyst target₩89,333
Pension summary
as of Oct 19streak5-day net sell
5D-₩1.0B
20D-₩10.8B
60D-₩22.4B
Foreign 20D+₩10.5B
Inst. 20D-₩19.9B
Pension daily net buy
-Cumulative net buying by investor
-선택 기간의 net buy Total · ₩100M
| Date | Close | Pension funds | Foreign | Institutions | Retail |
|---|---|---|---|---|---|
| 10/19 | 43,000 | -₩10M | +₩1.3B | -₩1.1B | -₩40M |
| 10/16 | 42,400 | -₩240M | +₩630M | +₩500M | -₩770M |
| 10/15 | 40,400 | -₩150M | +₩300M | +₩1.1B | -₩1.4B |
| 10/14 | 41,750 | -₩600M | +₩470M | -₩600M | +₩20M |
| 10/13 | 41,800 | -₩20M | +₩2.1B | -₩1.6B | -₩1.2B |
| 10/12 | 42,900 | +₩260M | +₩380M | +₩190M | -₩730M |
| 10/8 | 43,700 | -₩100M | +₩1.5B | -₩1.3B | -₩350M |
| 10/7 | 45,450 | +₩80M | -₩820M | -₩1.6B | +₩2.4B |
| 10/6 | 47,850 | -₩370M | +₩110M | +₩1.7B | -₩1.6B |
| 10/2 | 46,400 | -₩1.4B | -₩3.7B | -₩1.1B | +₩4.4B |
Discussion
Google-verified members · return since posting- Loading
Pension cost basis
Oct 19 Close · positions since 2024Pension cost basis55,923
Price vs. cost-23.1%
Holding value₩51.9B
Last 20 days-₩10.8B
Bought in the last 6 months only: avg. cost ₩56,456.
All pension cost data →세력 매집
last 60 trading days · Oct 19Foreign 60D+₩40.6B
Pension funds 60D−₩22.4B
세력 Avg. cost51,582
vs. cost Close-16.6%
Foreign+Pension funds Total 시총의 +0.8%, 60D price 폭 50%·Chg -12.7%. 세력 Avg. cost net buy한 날의 Avg 매수단가로 낸 est.치예요.
세력 매집 구간 All →Financial score
#440 of KOSPI 50038.5/100
- Value9.2
- Quality2
- Growth3
- Financials11.5
- Risk12.8
소외
All stock scores →ETF
ETFs holding it in their top 10 · recent changes10/08 이후 큰 ETF 변화는 없어요
ETFs holding the most
- KoAct 바이오헬스케어 Active6.3%
Recent filings
DART- Loading
Broker price targets
Recent 1YAvg83,000
High130,000
Low42,000
| Broker | Rating | Target | vs prior | Date |
|---|---|---|---|---|
| IBK Securities정OO | Buy | 70,000 | ▼4% | 26.09.28 |
| Shinhan Securities | Buy | 130,000 | ▲171% | 26.05.29 |
| Hyundai Motor Securities | Buy | 85,000 | ▲2% | 26.05.27 |
| Mirae Asset Securities | Buy | 71,000 | ▲61% | 26.05.21 |
| Eugene Investment & Securities | Buy | 100,000 | New | 26.04.20 |
| DS Securities | Sell | 42,000 | ▼16% | 26.04.03 |
Recent reports
- 하나가 빠져도, 신약가치 영향은 제한적IBK Securities · 09/28
- CLE 개발 중단, 시선은 다시 핵심 적응증으로Kiwoom Securities · 09/28
- 전세계 최초 성공, 1등을 사라Shinhan Securities · 05/29
- 2026 나는 다시 태어났다Hyundai Motor Securities · 05/27
- 1402, 성공의 신호탄Kyobo Securities · 05/22
Latest report per broker in the past year · Source: Naver Securities Research, Hankyung Consensus · Analyst names masked
Same sector
HANALL BIOPHARMA summary
HANALL BIOPHARMA (009420). Pension funds: -₩10.8B over the last 20 trading days; 5-day net selling streak. Market cap ₩2.26T, PER N/A, PBR 13.62×. Avg. analyst target ₩89,333. Pension flows are based on Korea Exchange investor statistics, for reference only.